The strong suppression of ERK, c-Jun and NF-κB signaling pathways by AKR7A3 reflects the multiple and complex molecular inhibition effects of this gene on the development and progression of HCC. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.